Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea

Oncology Reports

Volumn 16, Issue 5, 2006, Pages 1035-1039

  Lee, Kyoung Mu ^a   Kang, Daehee ^a   Lee, Seung Joon ^b   Park, Sue Kyung ^c   Lee, Kwan Hee ^d   Choi, Ji Yeob ^a   Kim, Soo Ung ^a   Choi, Hwang ^a   Choi, Seung Ho ^a   Kim, Young Whan ^a   Hong, Yun Chul ^a   Cho, Soo Hun ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Inha University School of Medicine   (South Korea)

Author keywords

CYP2E1; GSTM1; GSTT1; Interaction; Lung cancer; Smoking

Indexed keywords

CYTOCHROME P450 2E1; ENDODEOXYRIBONUCLEASE RSAI; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COCARCINOGENESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; HUMAN; KOREA; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; COCARCINOGENESIS; CYTOCHROME P-450 CYP2E1; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; GLUTATHIONE TRANSFERASE; HUMANS; KOREA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 39049194367     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.5.1035     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferly J and Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001. (Pubitemid 32911406)
2. Korean National Statistical Office: The census of death statistics, 2001.
3. Hecht SS: Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3: 461-469, 2002.
4. Kushida H, Fujita K, Suzuki A, Yamada M, Endo T, Nohmi T and Kamataki T: Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis 21: 1227-1232, 2000. (Pubitemid 30389351)
5. Persson I, Johansson I, Bergling H, Dahl M, Seidegard J, Rylander R, Rannung A, Hogberg J and Sundberg MI: Genetic polymorphism of cytochrome P4502E1 in a Swedish population: relationship to incidence of lung cancer. FEBS Lett 319: 207-211, 1993. (Pubitemid 23080213)
6. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR and Lau AF: Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58: 4858-4863, 1998. (Pubitemid 28503682)
7. Wang SL, Lee H, Chen KW, Tsai KJ, Chen CY and Lin P: Cytochrome P45021 genetic polymorphisms and lung cancer in a Taiwanese population. Lung Cancer 26: 27-34, 1999. (Pubitemid 29469713)
8. Watanabe J, Yang JP, Eguchi H, Hayashi S, Imai K, Nakachi K and Kawajiri K: An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn J Cancer Res 86: 245-248, 1995.
9. London SJ, Daly AK, Cooper J, Carpenter CL, Navidi WC, Ding L and Idle JR: Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics 6: 151-158, 1996. (Pubitemid 26151948)
10. Strange RC, Spiteri MA, Ramachandran S and Fryer AA: Glutathione-S- transferase family of enzymes. Mutat Res 482: 21-26, 2001. (Pubitemid 32787078)
11. Brockmoller J, Cascorbi I, Kerb R, Sachse C and Roots I: Polymorphisms in xenobiotic conjugation and disease predisposition. Toxicol Lett 102-103: 173-183, 1998. (Pubitemid 29022738)
12. Cuzick J: Interaction, subgroup analysis and sample size. In: Metabolic Polymorphisms and Susceptibility to Cancer. Vineis P, Malats N, Lang M, d'Errico A, Capraso N, Cuzick J and Boffeta P (eds). IARC Scientific Publication, Lyon, pp109-121, 1999.
13. Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, Butkiewicz D, Brockmoller J, Clapper ML, Daly A, Dolzan V, Ford J, Gaspari L, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, Ingelman-Sundberg M, Kalina I, Kihara M, Kremers P, Le Marchand L, London SJ, Nazar-Stewart V, Onon-Kihara M, Rannug A, Romkes M, Ryberg D, Seidegard J, Shields P, Strange RC, Stucker I, To-Figueras J, Brennan P and Taioli E: Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23: 1343-1350, 2002.
14. Lu W, Xing D, Qi J, Tan W, Miao X and Lin D: Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population. Int J Cancer 102: 275-279, 2002. (Pubitemid 35222299)
15. Persson I, Johansson I, Lou YC, Yue QY, Duan LS, Bertilsson L and Ingelman-Sundberg M: Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer 81: 325-329, 1999. (Pubitemid 29165187)
16. Wang J, Deng Y, Cheng J, Ding J and Tokudome S: GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 201: 185-193, 2003. (Pubitemid 37357168)
17. Chan-Yeung M, Tan-Un KC, Ip MS, Tsang KW, Ho SP, Ho JC, Chan H and Lam WK: Lung cancer susceptibility and polymorphisms of glutathione-S-transferase genes in Hong Kong. Lung Cancer 45: 155-160, 2004. (Pubitemid 38891477)
18. Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, Dienemann H, Kayser K, Schulz V, Spiegelhalder B and Bartsch H: Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small cell lung cancer subtypes and hamartomas. Pharmacogenetics 11: 757-764, 2001. (Pubitemid 33151510)
19. Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, Takei Y, Tsuchiya S, Saito R and Yokota J: Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 11: 730-738, 2002. (Pubitemid 34851907)
20. Nazar-Stewart V, Vaughan TL, Stapleton P, Van Loo J, Nicol-Blades B and Eaton DL: A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer 40: 247-258, 2003. (Pubitemid 36627704)
21. Lee SJ, Cho SH, Park SK, Kim SW, Park MS, Choi HY, Choi JY, Lee SY, Im HJ, Kim JY, Yoon KJ, Choi H, Shin SG, Park TW, Rothman N, Hirvonen A and Kang D: Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett 177: 173-179, 2002. (Pubitemid 34127918)
22. Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL and Bell DA: The role of N-acetylation polymorphism in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res 58: 3603-3610, 1998. (Pubitemid 28376558)
23. Taioli E, Zocchetti C and Garte S: Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Environ Health Perspect 106: 67-70, 1998. (Pubitemid 28143859)
24. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC and Taioli E: Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10: 1239-1248, 2001. (Pubitemid 34027754)
25. Lewis SJ, Cherry NM, Niven RM, Barber PV and Povey AC: GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett 180: 165-171, 2002. (Pubitemid 34327370)
26. Alexandrie AK, Nyberg F, Warholm M and Rannug A: Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish Population. Cancer Epidemiol Biomarkers Prev 13: 908-914, 2004. (Pubitemid 38756699)
27. Hirvonen A, Husgafvel-Pursiainen K, Anttila S and Vainio H: The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14: 1479-1481, 1993. (Pubitemid 23229700)
28. Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, Vainio H, Husgafvel-Pursiainen K and Hirvonen A: Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 77: 516-521, 1998. (Pubitemid 28340896)
29. Pinarbasi H, Silig Y, Cetinkaya O, Seyfikli Z and Pinarbasi E: Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. Cancer Genet Cytogenet 146: 125-129, 2003. (Pubitemid 37211310)
30. Wyner EL and Hoffman D: Smoking and lung cancer: scientific challenges and opportunities. Cancer Res 54: 5284-5295, 1994.
31. Kim JS, Park JY, Chae SC, Shin MC, Bae MS, Son JW, Kim KY, Kang TK, Park KS, Kim CH, Kam S and Jung TH: Changing trends of clinical aspects in lung cancer from 1988 to 1996. J Korean Cancer Assoc 31: 112-119, 1999.
32. Denissenko MF, Pao A, Tang M and Pfeifer GP: Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274: 430-432, 1996. (Pubitemid 26353359)
33. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994. (Pubitemid 24289415)
34. Alexandrov K, Cascorbi I, Rojas M, Bouvier G, Krief E and Bartsch H: CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis 23: 1969-1977, 2002. (Pubitemid 36104950)
35. Kihara M, Kihara M and Noda K: Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 15: 415-418, 1994. (Pubitemid 24121684)
36. Hou SM, Falt S and Nyberg F: Glutathione S-transferase T1-null genotype interacts synergistically with heavy smoking on lung cancer risk. Environ Mol Mutagen 38: 83-86, 2001.
37. Schneider J, Bernges U, Philipp M and Woitowitz HJ: GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett 208: 65-74, 2004. (Pubitemid 38501785)